01 2ACETAZOLAMIDE
02 1ADDERALL XR 10
03 1ADDERALL XR 15
04 1ADDERALL XR 20
05 1ADDERALL XR 25
06 1ADDERALL XR 30
07 1ADDERALL XR 5
08 1AGGRENOX
09 1APRISO
10 1APTENSIO XR
11 6ASPIRIN AND DIPYRIDAMOLE
12 1AVINZA
13 1CARBATROL
14 1CARDIZEM CD
15 1CARTIA XT
16 1CARVEDILOL PHOSPHATE
17 1CONZIP
18 9DEXMETHYLPHENIDATE HYDROCHLORIDE
19 7DEXTROAMP SACCHARATE, AMP ASPARTATE, DEXTROAMP SULFATE AND AMP SULFATE
20 5DEXTROAMPHETAMINE SULFATE
21 1DIAMOX
22 1DILATRATE-SR
23 1DILT-CD
24 8DILTIAZEM HYDROCHLORIDE
25 1DILTZAC
26 1EMBEDA
27 1FETZIMA
28 1FLUVOXAMINE MALEATE
29 1FOCALIN XR
30 2GALANTAMINE HYDROBROMIDE
31 9INDOMETHACIN
32 1KADIAN
33 1KAPSPARGO SPRINKLE
34 1KLOR-CON
35 1LUVOX CR
36 5MEMANTINE HYDROCHLORIDE
37 1MESALAMINE
38 3METHYLPHENIDATE HYDROCHLORIDE
39 2MORPHINE SULFATE
40 1NAMENDA XR
41 1PENTASA
42 1PHENDIMETRAZINE TARTRATE
43 5POTASSIUM CHLORIDE
44 1PROPAFENONE HYDROCHLORIDE
45 2PROPRANOLOL HYDROCHLORIDE
46 1RAZADYNE ER
47 1RYTARY
48 1TAZTIA XT
49 1TIAZAC
50 2TOLTERODINE TARTRATE
51 1TOPIRAMATE
52 2TROSPIUM CHLORIDE
53 1TROXYCA ER
54 7VENLAFAXINE HYDROCHLORIDE
55 1VERAPAMIL HYDROCHLORIDE
56 1VERELAN
57 1VERELAN PM
58 1XIMINO
59 1ZOHYDRO ER
Drug : NAMENDA XR
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 22525
Country : US
Patented : Yes
Drug : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204168
Country : US
Patented : Yes
Drug : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20616
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 200886
Country : US
Patented : No
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 78458
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 205673
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : DEXTROAMPHETAMINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 205077
Country : US
Patented : No
Strides Pharma Science: Pioneering IP-driven formulations for niche finished dosage forms.
Drug : MORPHINE SULFATE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 200812
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : TROSPIUM CHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 213185
Country : US
Patented : No
Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.
Drug : METHYLPHENIDATE HYDROCHLORIDE
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 211796
Country : US
Patented : No
